Thyrocare Technologies shares rallied more than 11% in morning trade after the company announced its quarterly results for the July–September 2025 period, along with a major bonus issue and interim dividend for shareholders.
The company declared a bonus issue of two shares for every one share held as on the record date, which will be announced later. This marks Thyrocare’s first-ever bonus issue since its listing. Notably, the diagnostics firm has already paid dividends totaling ₹143.5 per share since 2016.
Alongside the bonus shares, Thyrocare also announced an interim dividend of ₹7 per share, with the record date set for Friday, October 24, 2025.
Financially, the company reported a 22% year-on-year growth in revenue, reaching ₹216.5 crore in Q2FY26. Its EBITDA surged 47.5% YoY to ₹71.3 crore, while the EBITDA margin expanded sharply to 32.9%, up from 27.2% a year ago, reflecting improved operational efficiency.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
